The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
Post-Transplantation Cyclophosphamide for Tolerance Induction in HLA-Haploidentical Bone Marrow Transplantation
Open accessAbstract
Allogeneic hematopoietic stem cell transplantation (alloSCT) is a potentially curative therapy for many hematologic and immunologic diseases. Further, partial or full donor hematopoietic chimerism following alloSCT may be sufficient to guarantee immunologic tolerance to solid organs from the same donor, obviating any requirement for prolonged pharmacologic immunosuppression. Despite alloSCT’s potential, the procedure is beset by two major limitations. The first relates to the procedure’s toxicity including conditioning regimen toxicity, graft-versus-host disease (GVHD), and infection. The second limitation is the lack of histocompatible donors. A human leukocyte antigen (HLA)-matched sibling or unrelated donor cannot be identified expeditiously for up to 40% of patients. Historically, alloSCT from partially HLA-mismatched or HLA-haploidentical relatives has been complicated by unacceptably high incidences of graft rejection, severe GVHD, and non-relapse mortality. Recently, our groups have developed a method to selectively deplete alloreactive cells in vivo by administering high doses of cyclophosphamide in a narrow window after transplantation. Using high-dose, post-transplantation cyclophosphamide (PT/Cy), crossing the HLA barrier in alloSCT is now feasible and donors can be found for nearly all patients. This review discusses the history of HLA-haploidentical SCT, recent clinical results and immunologic mechanisms of action of high-dose PT/Cy for prevention of graft rejection and GVHD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants
Ruggeri, L., Capanni, M., Urbani, E., Perruccio, K., Shlomchik, W. D., Tosti, A., Posati, S., Rogaia, D., Frassoni, F., Aversa, F., et al. (2002) · Science · doi:10.1126/science.1068440 · Cited by 3,380
‘Actively Acquired Tolerance’ of Foreign Cells
BILLINGHAM, R. E., BRENT, L., & MEDAWAR, P. B. (1953) · Nature · doi:10.1038/172603a0 · Cited by 3,136
Luznik, L., O'Donnell, P. V., Symons, H. J., Chen, A. R., Leffell, M. S., Zahurak, M., Gooley, T. A., Piantadosi, S., Kaup, M., Ambinder, R. F., et al. (2008) · Biology of Blood and Marrow Transplantation · doi:10.1016/j.bbmt.2008.03.005 · Cited by 1,938
Self-citationMcSweeney, P. A., Niederwieser, D., Shizuru, J. A., Sandmaier, B. M., Molina, A. J., Maloney, D. G., Chauncey, T. R., Gooley, T. A., Hegenbart, U., Nash, R. A., et al. (2001) · Blood · doi:10.1182/blood.v97.11.3390 · Cited by 1,389
Immunogenetic Consequences of Vascular Anastomoses Between Bovine Twins
Owen, R. D. (1945) · Science · doi:10.1126/science.102.2651.400 · Cited by 1,368
Aversa, F., Tabilio, A., Velardi, A., Cunningham, I., Terenzi, A., Falzetti, F., Ruggeri, L., Barbabietola, G., Aristei, C., Latini, P., et al. (1998) · New England Journal of Medicine · doi:10.1056/nejm199810223391702 · Cited by 1,168
Tregs prevent GVHD and promote immune reconstitution in HLA-haploidentical transplantation
Di Ianni, M., Falzetti, F., Carotti, A., Terenzi, A., Castellino, F., Bonifacio, E., Del Papa, B., Zei, T., Ostini, R. I., Cecchini, D., et al. (2011) · Blood · doi:10.1182/blood-2010-10-311894 · Cited by 1,064
Marrow Transplantation from Related Donors Other Than HLA-Identical Siblings
Beatty, P. G., Clift, R. A., Mickelson, E. M., Nisperos, B. B., Flournoy, N., Martin, P. J., Sanders, J. E., Stewart, P., Buckner, C. D., Storb, R., et al. (1985) · New England Journal of Medicine · doi:10.1056/nejm198509263131301 · Cited by 816
Aversa, F., Terenzi, A., Tabilio, A., Falzetti, F., Carotti, A., Ballanti, S., Felicini, R., Falcinelli, F., Velardi, A., Ruggeri, L., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.09.117 · Cited by 707
Anasetti, C., Amos, D., Beatty, P. G., Appelbaum, F. R., Bensinger, W., Buckner, C. D., Clift, R., Doney, K., Martin, P. J., Mickelson, E., et al. (1989) · New England Journal of Medicine · doi:10.1056/nejm198901263200401 · Cited by 674
HYPOFERRÆMIA IN OBESE ADOLESCENTS
Wenzel, B., Stults, H., & Mayer, J. (1962) · The Lancet · doi:10.1016/s0140-6736(62)90110-1 · Cited by 650
Loss of Mismatched HLA in Leukemia after Stem-Cell Transplantation
Vago, L., Perna, S. K., Zanussi, M., Mazzi, B., Barlassina, C., Stanghellini, M. T. L., Perrelli, N. F., Cosentino, C., Torri, F., Angius, A., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0811036 · Cited by 529
O'Donnell, P. V., Luznik, L., Jones, R. J., Vogelsang, G. B., Leffell, M. S., Phelps, M., Rhubart, P., Cowan, K., Piantadosi, S., & Fuchs, E. J. (2002) · Biology of Blood and Marrow Transplantation · doi:10.1053/bbmt.2002.v8.pm12171484 · Cited by 491
Self-citationDrug-induced Immunological Tolerance
SCHWARTZ, R., & DAMESHEK, W. (1959) · Nature · doi:10.1038/1831682a0 · Cited by 479
Szydlo, R., Goldman, J. M., Klein, J. P., Gale, R. P., Ash, R. C., Bach, F. H., Bradley, B. A., Casper, J. T., Flomenberg, N., Gajewski, J. L., et al. (1997) · Journal of Clinical Oncology · doi:10.1200/jco.1997.15.5.1767 · Cited by 468
Transplantation of Anergic Histoincompatible Bone Marrow Allografts
Guinan, E. C., Boussiotis, V. A., Neuberg, D., Brennan, L. L., Hirano, N., Nadler, L. M., & Gribben, J. G. (1999) · New England Journal of Medicine · doi:10.1056/nejm199906033402202 · Cited by 429
High-dose cyclophosphamide as single-agent, short-course prophylaxis of graft-versus-host disease
Luznik, L., Bolaños-Meade, J., Zahurak, M., Chen, A. R., Smith, B. D., Brodsky, R., Huff, C. A., Borrello, I., Matsui, W., Powell, J. D., et al. (2010) · Blood · doi:10.1182/blood-2009-11-251595 · Cited by 409
Self-citationLeen, A. M., Christin, A., Myers, G. D., Liu, H., Cruz, C. R., Hanley, P. J., Kennedy-Nasser, A. A., Leung, K. S., Gee, A. P., Krance, R. A., et al. (2009) · Blood · doi:10.1182/blood-2009-07-232454 · Cited by 333
Kasamon, Y. L., Luznik, L., Leffell, M. S., Kowalski, J., Tsai, H.-L., Bolaños-Meade, J., Morris, L. E., Crilley, P. A., O'Donnell, P. V., Rossiter, N., et al. (2010) · Biology of Blood and Marrow Transplantation · doi:10.1016/j.bbmt.2009.11.011 · Cited by 281
Self-citationBurroughs, L. M., O'Donnell, P. V., Sandmaier, B. M., Storer, B. E., Luznik, L., Symons, H. J., Jones, R. J., Ambinder, R. F., Maris, M. B., Blume, K. G., et al. (2008) · Biology of Blood and Marrow Transplantation · doi:10.1016/j.bbmt.2008.08.014 · Cited by 266
Self-citationAmrolia, P. J. (2006) · Blood · doi:10.1182/blood-2006-02-001909 · Cited by 239
Ciurea, S. O., Thall, P. F., Wang, X., Wang, S. A., Hu, Y., Cano, P., Aung, F., Rondon, G., Molldrem, J. J., Korbling, M., et al. (2011) · Blood · doi:10.1182/blood-2011-06-362111 · Cited by 228
Ash, R. C., Horowitz, M. M., Gale, R. P., et al. (1991) · PubMed · Cited by 199
Sustained suppression by Foxp3+ regulatory T cells is vital for infectious transplantation tolerance
Kendal, A. R., Chen, Y., Regateiro, F. S., Ma, J., Adams, E., Cobbold, S. P., Hori, S., & Waldmann, H. (2011) · Journal of Experimental Medicine · doi:10.1084/jem.20110767 · Cited by 199
Luznik, L., & Fuchs, E. J. (2010) · Immunologic Research · doi:10.1007/s12026-009-8139-0 · Cited by 196
Self-citationSymons, H. J., Leffell, M. S., Rossiter, N. D., Zahurak, M., Jones, R. J., & Fuchs, E. J. (2010) · Biology of Blood and Marrow Transplantation · doi:10.1016/j.bbmt.2009.11.022 · Cited by 186
Self-citationSTRAUSS, G., OSEN, W., & DEBATIN, K.-M. (2002) · Clinical and Experimental Immunology · doi:10.1046/j.1365-2249.2002.01777.x · Cited by 185
Haploidentical hematopoietic transplantation: current status and future perspectives
Reisner, Y., Hagin, D., & Martelli, M. F. (2011) · Blood · doi:10.1182/blood-2011-07-338822 · Cited by 165
An update on regulatory T cells in transplant tolerance and rejection
Li, X. C., & Turka, L. A. (2010) · Nature Reviews Nephrology · doi:10.1038/nrneph.2010.101 · Cited by 137
Cyclophosphamide-Induced Immunological Tolerance: an Overview
Mayumi, H., Umesue, M., & Nomoto, K. (1996) · Immunobiology · doi:10.1016/s0171-2985(96)80033-7 · Cited by 137
Villalobos, I. B., Takahashi, Y., Akatsuka, Y., Muramatsu, H., Nishio, N., Hama, A., Yagasaki, H., Saji, H., Kato, M., Ogawa, S., et al. (2010) · Blood · doi:10.1182/blood-2009-11-254284 · Cited by 111
Eto, M., Mayumi, H., Tomita, Y., et al. (1990) · The Journal of Experimental Medicine · doi:10.1084/jem.171.1.97 · Cited by 105
Eto, M., Mayumi, H., Tomita, Y., Yoshikai, Y., Nishimura, Y., Maeda, T., Ando, T., & Nomoto, K. (1991) · The Journal of Immunology · doi:10.4049/jimmunol.146.5.1402 · Cited by 84
Allogeneic Marrow Engraftment Following Whole Body Irradiation in a Patient with Leukemia
Buckner, C. D., Epstein, R. B., Rudolph, R. H., Clift, R. A., Storb, R. F., & Thomas, E. D. (2001) · Stem Cells and Development · doi:10.1089/15258160151134845 · Cited by 80
Allogeneic Marrow Engraftment Following Whole Body Irradiation in a Patient with Leukemia
Buckner, C. D., Epstein, R. B., Rudolph, R. H., Clift, R. A., Storb, R. F., & Thomas, E. D. (1970) · Blood · doi:10.1182/blood.v35.6.741.741 · Cited by 69
Perruccio, K., Topini, F., Tosti, A., Carotti, A., Aloisi, T., Aversa, F., Martelli, M. F., & Velardi, A. (2007) · Blood Cells Molecules and Diseases · doi:10.1016/j.bcmd.2007.06.022 · Cited by 68
Tolerance: an overview and perspectives
Waldmann, H. (2010) · Nature Reviews Nephrology · doi:10.1038/nrneph.2010.108 · Cited by 47
Gibbons, C., & Sykes, M. (2008) · Immunological Reviews · doi:10.1111/j.1600-065x.2008.00636.x · Cited by 32
Cited by
An update of current treatments for adult acute myeloid leukemia
Dombret, H., & Gardin, C. (2016) · Blood · doi:10.1182/blood-2015-08-604520 · Cited by 550
The effect of cyclophosphamide on the immune system: implications for clinical cancer therapy
Ahlmann, M., & Hempel, G. (2016) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-016-3152-1 · Cited by 499
Cooke, K. R., Luznik, L., Sarantopoulos, S., Hakim, F. T., Jagasia, M., Fowler, D. H., van den Brink, M. R. M., Hansen, J. A., Parkman, R., Miklos, D. B., et al. (2017) · Biology of Blood and Marrow Transplantation · doi:10.1016/j.bbmt.2016.09.023 · Cited by 472
Self-citationTodo, S., Yamashita, K., Goto, R., Zaitsu, M., Nagatsu, A., Oura, T., Watanabe, M., Aoyagi, T., Suzuki, T., Shimamura, T., et al. (2016) · Hepatology · doi:10.1002/hep.28459 · Cited by 441
Modern approaches to HLA-haploidentical blood or marrow transplantation
Kanakry, C. G., Fuchs, E. J., & Luznik, L. (2016) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2015.128 · Cited by 330
Self-citation
Metadata
- Authors
- Luznik, L., O'Donnell, P. V., & Fuchs, E. J.
- Venue
- Seminars in Oncology
- Publisher
- Elsevier BV
- Published
- 2012-12
- Volume
- 39
- Issue
- 6
- Pages
- 683-693
- ISSN
- 0093-7754 (ISSN-L)
- OpenAlex
- W2066886754
- Cited by
- 336
- References
- 38
- FWCI
- 11.52
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.